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ORIGINAL ARTICLE
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Abstract
Pregnancy and breastfeeding make demands on maternal nutrient stores. The extent of
depletion and the degree to which nutrient stores are replenished between pregnancies
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has implications for a mother's nutritional status at conception of the subsequent child
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and therefore that child's birth outcomes and growth. Using follow-up data collected
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several years after a randomized effectiveness trial conducted in rural Bangladesh and
a randomized efficacy trial conducted in semiurban Ghana, we evaluated the impact of
maternal supplementation with small-quantity lipid-based nutrient supplements (LNS)
or multiple micronutrients (MMN) through pregnancy (the index pregnancy) and
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6 months postpartum on the growth status of the next living younger sibling conceived
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received LNS (or MMN, Ghana only) during and after the index pregnancy compared

and born after the index pregnancy. In both Bangladesh (n = 472 younger siblings) and
Ghana (n = 327 younger siblings), there were no overall differences in the growth status or the prevalence of undernutrition among younger siblings whose mothers had
with the younger siblings of mothers who had received iron plus folic acid (IFA) during
the index pregnancy (Ghana) or during and for 3 months after the index pregnancy
(Bangladesh). These findings do not indicate that preconception nutrition interventions
do not improve child growth. Rather, they suggest that any benefits of maternal LNS or
MMN supplementation during one pregnancy and for 6 months postpartum are
unlikely to extend to the growth of her next child beyond any effects due to IFA alone.
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I N T RO DU CT I O N
Key messages

The first 1,000 days, spanning the period from conception through
24 months of age, is often referred to as the “critical window of
opportunity” for improving maternal and child nutrition (de Onis &
Branca, 2016; Victora et al., 2010). Poor maternal and child nutrition
during this period increases morbidity and mortality and can have
adverse long-term effects on health, cognitive development, human
capital acquisition, and economic productivity in adulthood (Black
et al., 2013; World Bank, 2006). For this reason, many nutrition interventions focus on improving maternal nutrition during pregnancy
and/or child nutrition during the first 2 years. More recently, the preconception period has received increasing attention as another critical, and generally overlooked, window for improving maternal
nutrition and child outcomes (Barker et al., 2018; De-Regil, Harding, &
Roche, 2016; Stephenson et al., 2018).
The preconception period, which is any interval of time in which a
woman of reproductive age (15–49 years) is not pregnant, includes
the period before first pregnancy and any interpregnancy intervals
(De-Regil et al., 2016). Several studies have shown a significant association between preconception maternal nutritional status and birth
outcomes (Ramakrishnan et al., 2012; Young et al., 2015) or preconception maternal nutrition and child growth (Young et al., 2018). How-

• Although maternal supplementation with small-quantity
lipid-based nutrient supplements or multiple micronutrients during pregnancy and for 6 months postpartum
is likely to improve maternal nutrition prior to the next
pregnancy, we did not find a significant impact on the
growth status of the subsequent child, compared with
maternal supplementation with iron plus folic acid.
• Maternal supplementation with small-quantity lipidbased nutrient supplements ormultiple micronutrients
during pregnancy and for six months postpartum is likely
toimprove maternal nutrition prior to the next pregnancy.
• We did not find a significant impact on the growth status
of the subsequent child,compared to maternal supplementation with iron plus folic acid.
• In these studies, the average gap between the end of
maternal supplementation andconception of the next
child was 15 months in Bangladesh and 25 months
inGhana; in such scenarios, improvements in maternal
nutrition may not be sustainedthrough conception of the
subsequent child.

ever, the global nutrition community has focused mainly on the first
1,000 days as the critical window of opportunity for improving birth
outcomes and child growth, and the potential role of maternal nutrition during the preconception period has only recently gained atten-

impact of maternal supplementation during pregnancy (the index

tion (Bhutta, 2019). Thus, there is limited evidence on the impact of

pregnancy) and the first 6 months postpartum on the growth status of

maternal nutrition interventions during the preconception period,

her next living child conceived after the index pregnancy. Our ana-

including the importance of the specific timing and duration of the

lyses were based on follow-up data that were collected several years

preconception intervention, on birth outcomes and child growth. A

after two randomized controlled trials: the Rang-Din Nutrition Study

few studies have evaluated the effect of preconception nutrition

(RDNS) effectiveness trial in Bangladesh and the International Lipid-

interventions on birth outcomes (Hambidge et al., 2019; Nguyen

based Nutrient Supplements-DYAD-G efficacy trial in Ghana. These

et al., 2017; Potdar et al., 2014; Ramakrishnan et al., 2016). In the

trials were designed to assess the impact of combined maternal and

most recent trial, conducted in four low- and middle-income coun-

child supplementation throughout much of the first 1,000 days on

tries, maternal supplementation with a lipid-based nutrient supple-

child birth and growth outcomes (Adu-Afarwuah et al., 2016; Adu-

ment (LNS) starting at least 3 months before conception improved

Afarwuah et al., 2015; Dewey et al., 2017; Mridha et al., 2016). During

foetal growth, but the impact on foetal growth did not significantly

pregnancy and for 6 months postpartum, women who participated in

differ from the impact observed when the supplement was started

the trials were provided with daily small-quantity (20 g/day; 118 kcal/

late in the first trimester (Hambidge et al., 2019). Whether preconcep-

day) LNS (both trials) or MMN capsules (DYAD-G trial only), whereas

tion nutrition has an effect on growth measured later in childhood

other women received daily iron-folic acid (IFA) capsules during preg-

remains relatively unknown. One study in Vietnam showed improved

nancy and for 3 months postpartum (RDNS trial) or during pregnancy

linear growth at 2 years of age among children whose mothers had

only (DYAD-G trial). The infants born to women during the trials,

received preconception multiple micronutrients (MMN) or iron and

referred to here as index children, also participated in the trials, with

folic acid compared with those who had received preconception folic

children in some arms receiving supplements from 6 to 18 or

acid (Nguyen et al., 2017), but more evidence is needed.

24 months of age (described in detail in the methods section).

In this study, we contribute new evidence on the impact of

The effects of these interventions on index child and maternal

maternal nutrient supplementation prior to conception on child

outcomes varied across the two trials. In Bangladesh, maternal supple-

growth status. Although most preconception maternal nutrition inter-

mentation with LNS during pregnancy improved several birth out-

vention trials have provided mothers with supplementation during the

comes, including a reduction in the prevalence of newborn stunting

preconception period immediately before conception and through

(Mridha et al., 2016), and comprehensive LNS supplementation

delivery, we explored the relationship from a different time point dur-

(maternal supplementation during pregnancy and the first 6 months

ing the maternal preconception period. Specifically, we assessed the

postpartum plus child supplementation from 6 to 24 months of age)
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improved child growth and development through 24 months of age

maternal supplementation with LNS, or with MMN, during pregnancy

(Dewey et al., 2017; Matias et al., 2017). In the mothers, those in the

and the first 6 months postpartum, compared with maternal supple-

LNS group experienced less household food insecurity (Adams et al.,

mentation with IFA during pregnancy only or during pregnancy and

2017) and improved anthropometric indices during pregnancy among

the first 3 months postpartum, may have led to improved maternal

those >25 years (Matias et al., 2016), but no differences in vitamin A

nutritional status at the conception of the subsequent child, thereby

status during pregnancy (Dewey et al., 2016) or in anaemia, iron sta-

improving the younger siblings' growth status.

tus, or iodine status at 6 months postpartum (Matias et al., 2018;
Mridha et al., 2017). In Ghana, maternal supplementation with LNS
during pregnancy increased birth size, particularly among infants of

2

METHODS

|

first-time mothers (Adu-Afarwuah et al., 2015), and mean attained
length at 18 months of age was higher among children in the compre-

2.1

|

Randomized trials

hensive maternal and child LNS supplementation group (AduAfarwuah et al., 2016). In the mothers, those in the LNS group were

The RDNS trial was implemented by University of California, Davis, in

less likely to experience inadequate weight gain during pregnancy

partnership with the International Center for Diarrheal Diseases

(Adu-Afarwuah et al., 2017a) and had improved essential fatty-acid

Research, Bangladesh, LAMB, and the Food and Nutrition Technical

status during pregnancy and postpartum (Oaks et al., 2017), and those

Assistance III Project of Family Health International 360. RDNS was a

who received LNS or MMN had improved vitamin B12 (Shahab-Fer-

cluster-randomized effectiveness trial conducted in 11 rural unions of

dows et al., 2019) and iodine status (Adu-Afarwuah et al., 2018) but

the Badarganj and Chirirbandar subdistricts in the northwest region of

did not differ in anaemia, iron status, or breast milk vitamin A concen-

Bangladesh. LAMB, one of the implementing partners, was a non-

tration at 6 months postpartum or in household food insecurity, com-

governmental organization that provided community-based health

pared with those who received IFA (Adams et al., 2017; Adu-

services to women and children in the study area. LAMB community

Afarwuah et al., 2017b; Klevor et al., 2016).

health workers delivered the supplements to women and children

As part of the follow-up to the randomized trials, we collected
anthropometric data on the next child born after the index pregnancy

who participated in the trial, and study clusters were defined based
on the LAMB community health workers' 64 work areas.

and evaluated the impact of maternal supplementation with LNS or

Pregnant women who were 20 weeks of gestation or less were

with MMN, compared with maternal supplementation with IFA, on

enrolled into the RDNS trial on a rolling basis between October 2011

the growth status of these younger siblings. We hypothesized that

and August 2012. Enrolled women (n = 4,011) were assigned to one

TABLE 1

Rang-Din Nutrition Study and DYAD-G intervention groups as defined during the main trials and for follow-up sibling analyses

RDNS intervention groups
Main trial

Follow-up younger sibling analysisa

(1) Comprehensive LNS: Women received 20 g of LNS per day through pregnancy and the first 6 months
postpartum, and their children received 20 g of LNS per day from 6–24 months of age.

(1) LNS (Comprehensive LNS)

(2) Child-only LNS: Women received daily IFA capsules during pregnancy and the first 3 months postpartum,
and their children received 20 g LNS from 6–24 months.

(2) IFA (Child-only LNS + Child-only
MNP + Control)

(3) Child-only MNP: Women received daily IFA capsules during pregnancy and the first three months
postpartum, and their children received micronutrient powder from 6–24 months.
(4) Control: Women received daily IFA capsules during pregnancy and the first 3 months postpartum
(no child supplementation).
DYAD-G intervention groups
Main trial

Follow-up younger sibling analysisb

(1) LNS: Women received 20 g/day LNS during pregnancy and the first 6 months postpartum followed by
20 g/day LNS for the infant from 6 to 18 months of age.

(1) LNS

(2) MMN: Women received daily multiple micronutrient capsules during pregnancy and the first 6 months
postpartum and no infant supplementation.

(2) MMN

(3) IFA: Women received daily iron–folic acid capsules during pregnancy, a low-dose calcium placebo capsule
for the first 6 months postpartum and no infant supplementation.

(3) IFA

Abbreviations: IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN, multiple micronutrient; MNP, micronutrient powder.
a
The current analysis was conducted using follow-up data collected several years after the “main trial,” a randomized effectiveness trial in Bangladesh.
Intervention groups for the follow-up analysis were as defined in the “follow-up younger sibling analysis” column.
b
The current analysis was conducted using follow-up data collected several years after the “main trial,” a randomized efficacy trial in Ghana. Intervention
groups for the follow-up analysis were as defined in the “follow-up younger sibling analysis” column.
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of four intervention groups (defined in Table 1) based on their resi-

cases of younger sibling twins, both twins were measured, and one

dence within one of the 64 clusters, with 16 randomly assigned clus-

twin was randomly selected for inclusion in the younger sibling

ters per arm. The original RDNS minimum sample size calculation of

analyses.

778 women per group (total of 3,152 women) was based on detecting

For eligible younger siblings who participated in the follow-up

an effect size of 0.2 for comparison of continuous outcomes between

study, anthropometric measurements were taken at a central location

any two groups with a one-sided hypothesis test at the 5% level of

or in participants' homes. A team of anthropometrists trained to

significance with 80% power and assuming an intracluster correlation

World Health Organization (WHO) standards performed all sibling

of 0.01 (Mridha et al., 2016).

anthropometric measurements according to WHO standard proce-

The DYAD-G trial was implemented by the Lipid-based Nutrient

dures (de Onis et al., 2004). The recumbent length of siblings under

Supplements Project between December 2009 and March 2014 in

24 months of age (or under 85 cm in DYAD-G) was measured to the

the semiurban Yilo Krobo and Lower Manya Krobo districts of the

nearest 0.1 cm using an infantometer, whereas standing height of

Eastern Region of Ghana. Between December 2009 and December

those 24 months of age and older was measured to the nearest

2011, pregnant women who were 20 weeks of gestation or less and

0.1 cm using a stadiometer. For all younger siblings, weight was mea-

at least 18 years of age were enrolled on a rolling basis. Women were

sured to the nearest 50 g using an electronic scale (Seca 874), and a

randomly assigned to one of three intervention groups (Table 1).

Shorr tape was used to measure mid-upper arm circumference and

The DYAD-G sample size calculations were based on detecting an

head circumference to the nearest 0.1 cm.

effect size of 0.3 for comparison of continuous outcomes between

In Ghana, anthropometric data were entered into tablets that

any two groups with a two-sided hypothesis test at the 5% level of

were preprogrammed using Open Data Kit software. The Open Data

significance and with 80% power (Adu-Afarwuah et al., 2015).

Kit data entry forms included preprogrammed quality checks to

Because of a temporary mislabelling of the IFA and MMN supple-

ensure data were entered for all relevant questions/measurements

ments (described later), additional women were enrolled to allow for

and to prevent entry of implausible values. All measurements were

sufficient power to assess pregnancy outcomes if women who

performed twice and, once entered into the form, were automatically

temporarily received a mislabelled supplement were excluded. In total,

compared for agreement. If the difference between the first two mea-

1,320 women were enrolled and randomized (n = 440 for the LNS

surements exceeded a predefined threshold (>0.5 cm for length/

group, n = 439 for the MMN group, and n = 441 for IFA group;

height, mid-upper arm circumference, and head circumference;

Adu-Afarwuah et al., 2015).

>0.1 kg for weight), the anthropometrists received a software-gener-

The nutrient composition of each of the maternal supplements is

ated prompt to take and enter a third measurement. In Bangladesh,

provided in Table S1 in the online supporting material (OSM). Both

anthropometric data were collected on paper forms. The difference in

main trials received ethical approval and were registered at

the first two anthropometric measurements was manually calculated,

clinicaltrials.gov.

and a third measurement was taken if the difference between the first
two measurements exceeded the same predefined thresholds as were
used in Ghana.

2.2

|

Follow-up data collection

The University of California, Davis and the Center for Diarrheal
Diseases Research, Bangladesh provided ethical approval for the

Several years after the completion of each of the main trials, we car-

RDNS follow-up study as a modification to the main study protocol.

ried out follow-up studies to collect additional data from the mothers

The DYAD-G follow-up study received approval from the ethics com-

who had participated in the trials, the index children, and other mem-

mittees of the University of California, Davis, the Ghana Health Ser-

bers of the index children's families. The RDNS follow-up occurred

vice, and the University of Ghana College of Basic and Applied

from January to August 2016, when the index children were ~40–

Sciences. Prior to participation in both follow-up studies, mothers

52 months of age, whereas the follow-up to the DYAD-G trial

(or caregivers) provided written informed consent.

occurred between January and December of 2016 when the index
children were 4–6 years of age. All of the women who participated in
the main trials as well as the index children born during the main trials
were eligible to participate in the follow-up study.

2.3 | Younger sibling subsample and statistical
analysis

As a component of the follow-up data collection activities in both
countries, we collected anthropometric data on the closest younger

Our analyses assessed the impact of maternal LNS or MMN supple-

living sibling born after the index child. All closest younger siblings

mentation during the index pregnancy and for the first 6 months post-

born after the index children were eligible for follow-up anthropomet-

partum on the growth of the next living child conceived after the

ric measurements with several exceptions. We did not attempt to col-

index pregnancy. To evaluate this impact, we generated younger sib-

lect sibling anthropometric data in cases where the woman who

ling anthropometric outcomes on the basis of the WHO 2006 Growth

participated in the main trial or the index child had died, nor did we

Standards (WHO, 2006). These outcomes were length-for-age

attempt follow-up data collection when the woman had a misdi-

z score/height-for age z score, weight-for-age z score, weight-for-

agnosed pregnancy, miscarriage, or stillbirth during the main trial. In

length z score/weight-for-height z score, body mass index (BMI)-for

ADAMS ET AL.
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age z score, head circumference-for-age z score (HCZ), and mid-upper

adjustment. We also conducted two additional sets of DYAD-G ana-

arm circumference-for-age z score. We defined sibling stunting as

lyses. First, where no differences between the IFA and MMN groups

length-for-age z score/height-for age z score < −2, wasting as weight-

were found, we conducted secondary analyses to test for differences

for-length z score/weight-for-height z score < −2, and underweight as

between the LNS group and the combined IFA and MMN groups. Sec-

weight-for-age z score< −2.

ond, during the main trial, a temporary mislabelling of the capsules

We developed a statistical analysis plan prior to conducting the

provided to women during pregnancy (described in Adu-Afarwuah

analyses. All analyses were performed using SAS version 9.4 (SAS Inst.

et al., 2015) meant that 170 women assigned to the IFA group actu-

Cary, NC, USA). Hypothesis tests were two-sided at the 5% level of

ally received MMN capsules for part or all of their pregnancy (and IFA

significance. On the basis of the full samples of women initially ran-

for the remainder of the maternal supplementation period), whereas

domized into the main trials, we began by assessing the overall and

170 women assigned to the MMN group actually received IFA cap-

group-specific rates of attrition at follow-up. We tested for by-group

sules for part or all of their pregnancy (then MMN for the remainder

differences in attrition and summarized and compared the background

of the maternal supplementation period). We therefore conducted an

characteristics between the follow-up and lost to follow-up samples.

additional “as received” analyses in which group assignments cor-

We also assessed by-group differences in the proportion of index chil-

responded to the supplements women actually received at

dren who had a younger sibling in the follow-up sample.

enrollment.

We assessed balance in three ways. First, we summarized and

The statistical models estimated to detect by-group differences in

compared the baseline characteristics of the follow-up and lost to fol-

sibling anthropometric outcomes were site-specific to account for the

low-up samples, which were defined based on the initial randomiza-

differing designs of each of the main trials. For the RDNS follow-up

tions. Next, among the full follow-up sample, we summarized and

sibling sample, continuous outcomes were modelled using mixed-

tested for differences in background characteristics between those

model linear regression, whereas mixed-model logistic regressions

with and without a younger sibling. Finally, among the follow-up sam-

were used to analyse dichotomous sibling outcomes. Each of the

ple with a younger sibling, we summarized background characteristics

mixed models accounted for the regionally cluster-randomized design

and tested for differences in these characteristics by intervention

of the main RDNS trial by including the effect of union (nested within

group. Background characteristics included a household asset index

subdistrict) and the random effect of cluster (nested within interven-

score and the household food insecurity access scale score. Principal

tion group). With our RDNS observed sample size of 472 younger sib-

components analysis was used to construct the asset index based on

lings and assuming a two-sided hypothesis test at the 5% level of

household ownership of a set of assets, housing characteristics, and

significance with 80% power and an intracluster correlation of 0.01, in

water and sanitation sources, where a higher score indicated a rela-

two-group comparisons, we had sufficient power to detect a mean

tively better socioeconomic status (Vyas & Kumaranayake, 2006). The

difference of >0.36 SD for continuous outcomes, and using the con-

household food insecurity access scale score, which ranged from 0 to

trol group stunting rate as the reference prevalence of stunting, a dif-

27 with a higher score indicating more severe food insecurity, was

ference of >16% in stunting.

based on self-reported answers about the frequency of experiencing

Randomization in the DYAD-G main trial was at the individual

each of nine food insecurity access conditions (Coates, Swindale, &

level, so continuous and dichotomous outcomes for younger sib-

Bilinsky, 2007).

lings in the DYAD-G follow-up sample were modelled using ordi-

The primary analyses were by intention-to-treat, that is, by-group

nary least squares and logistic regression, respectively. With our

analyses were according to group assignment regardless of any proto-

DYAD-G observed sample size of roughly 300 younger siblings and

col violations. We also performed a secondary per-protocol analysis

again assuming a two-sided hypothesis test at the 5% level of sig-

on the basis of self-reported maternal adherence to her assigned sup-

nificance with 80% power, we had sufficient power to detect a

plement during the main trial. In particular, the per-protocol samples

mean difference of >0.36 SD in two group comparisons and a

were limited to the next youngest children of women with at least

mean difference of >0.46 SD in three-group comparisons of contin-

60% reported adherence during pregnancy and the period of postpar-

uous outcomes. Using the control group stunting rate as the refer-

tum supplementation.

ence prevalence of stunting, we had power to detect a difference

For RDNS, the by-group primary and per-protocol analyses compared two groups on the basis of assigned maternal supplement

in stunting of >12% in two-group comparisons and >14% in threegroup comparisons.

(Table 1): LNS (comprehensive LNS groups) versus IFA (combined

For both RDNS and DYAD-G, all models included a fixed-effect

child-only LNS, child-only micronutrient powder, and control groups).

control for sibling age at the time of measurement. Fully adjusted ana-

Exploratory analyses were also conducted to test for differences

lyses included sibling age at the time of measurement in addition to

among the four child intervention arms. The DYAD-G primary and

other prespecified covariates, potentially including maternal age at

per-protocol analyses were based on tests for differences among the

enrollment, maternal years of education at enrollment, maternal

three intervention groups (LNS, MMN, and IFA). When the global null

height at enrollment, predicted maternal prepregnancy BMI, maternal

hypothesis of no difference between the three groups was rejected at

parity at enrollment, household asset index score, household food

the 5% level, we performed post hoc pairwise group comparisons

insecurity access scale score, younger sibling age at growth measure-

corrected for multiple hypothesis testing using the Tukey–Kramer

ment, younger sibling sex, and birth interval between index child and

6 of 12
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younger sibling. Among the potential covariates, only those that were

The baseline characteristics of the follow-up and lost to follow-up

at least marginally associated (p < .1) with a specific sibling anthropo-

samples are summarized and compared in Table S2. In both the RDNS

metric outcome in bivariate analysis were included in the fully

(top panel) and DYAD-G (bottom panel) samples, there were statisti-

adjusted regression model for that outcome.

cally significant differences in the characteristics of the follow-up and
lost to follow-up samples, though in all cases, the magnitude of the
differences was small.

3

RESULTS

|

Of the 3,440 households in the RDNS follow-up sample,
472 (13.7%) had a younger sibling with anthropometric data. Among

3.1

|

Attrition and balance

households in the overall follow-up sample, 16.1% in the LNS group
had a younger sibling compared with 12.9% in the IFA group (p = .04).

The RDNS main trial enrolled 4,011 women. Data of any kind were

In Ghana, 327 of the 1,440 households (31.4%) in the DYAD-G follow-

collected from 3,440 households at the 40–52-month follow-up,

up sample had a younger sibling with anthropometric data, which did

resulting in an overall attrition rate of 14.2%, which did not differ

not differ by group (29.8% [LNS] vs. 34.2% [MMN] vs. 30.4% [IFA], p =

between intervention groups (14.1% in the LNS group vs. 14.3% in

.569). Table 2 summarizes and compares the background characteris-

the IFA group, p = .940). Excluding households that were not targeted

tics of these two groups (those with a younger sibling with anthropo-

for follow-up because of miscarriage or stillbirth during the main trial

metric data and those without a younger sibling) within the follow-up

or because the index child had died before the end of the main trial,

samples. In the RDNS follow-up sample, compared with those without

the rate of successful follow-up was 98.3% (3,440/3,499).

a younger sibling in the follow-up sample, the mothers of those with a

The DYAD-G main trial enrolled 1,320 women, and follow-up

younger sibling were younger and more likely to be nulliparous when

data of any kind were collected from 1,040 households at the 4–6-

they enrolled in the main trial and had a slightly lower prepregnancy

year follow-up. The overall DYAD-G attrition rate at follow-up was

(prior to the index pregnancy) BMI and slightly lower household asset

therefore 21.2%, which was marginally significantly different between

index scores. In the DYAD-G follow-up sample, households with a

intervention groups (17.7% in the LNS group vs. 22.8% in the MMN

younger sibling tended to include mothers who were younger when

group vs. 23.1% in the IFA group, p = .092). Again excluding house-

they enrolled in the main trial, mothers who were slightly taller, and

holds that were not targeted for follow-up (due to miscarriage, still-

mothers for whom the first child was the index child.

birth, or index-child death during the main trial), the DYAD-G rate of

terms of baseline characteristics and background characteristics (sex

successful follow-up was 85.1% (1,040/1,222).

TABLE 2

Table 3 shows that the intervention groups were balanced in

Baseline characteristics of follow-up samples with and without a younger sibling
Has younger sibling

No younger sibling

Trial

Variable

N

M ± SD or %a

N

M ± SD or %a

p valueb

RDNS

Maternal age (y)

472

20.2 ± 3.8

2968

22.2 ± 5.0

<.001

Maternal education (y)

472

6.0 ± 3.1

2968

6.3 ± 3.3

.091

Maternal height (cm)

472

150.4 ± 5.4

2968

150.7 ± 5.4

.238

2

DYAD-G

Maternal prepregnancy BMI (kg/m )

472

19.8 ± 2.6

2968

20.0 ± 2.7

.029

Mother nulliparous at index pregnancy (%)

472

58.5

2965

36.5

<.001

Household asset index score

472

−0.2 ± 2.2

2968

0.1 ± 2.3

.008

HFIAS score (0–27)

472

3.3 ± 4.3

2968

2.9 ± 3.9

.137

Maternal age (y)

327

25.7 ± 4.6

713

27.3 ± 5.7

<.001

Maternal education (y)

327

7.9 ± 3.5

713

7.6 ± 3.6

.220

Maternal height (cm)

323

159.5 ± 5.6

700

158.7 ± 5.7

.050

Maternal prepregnancy BMI (kg/m2)

322

24.3 ± 4.1

700

24.7 ± 4.6

.111

Mother nulliparous at index pregnancy (%)

327

37.9

713

29.6

.008

Household asset index score

327

0.0 ± 1.0

710

0.0 ± 1.0

.678

HFIAS score (0–27)

325

2.3 ± 3.8

708

2.7 ± 4.4

.116

Note. The values of baseline characteristics are from the baseline of the main randomized trials.
Abbreviations: BMI, body mass index; HFIAS, household food insecurity access scale.
a
Values are M ± SD for continuous variables and percentage for dichotomous variables.
b
For continuous variables, p values for tests of difference in mean between follow-up samples with and without a younger sibling based on mixed model
linear regressions (RDNS) or ordinary least squares regressions (DYAD-G). For dichotomous variables, p values for tests of difference in proportion
between follow-up samples with and without a younger sibling based on mixed model logistic regressions (RDNS) or logit regressions (DYAD-G).
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Characteristics of follow-up sample with younger sibling by intervention group
LNS

Trial
RDNS

N

Variable
a

Maternal age (y)

M ± SD or %b

145 19.9 ± 3.4
a

DYAD-G

IFA
N

MMN
M ± SD or %b

N

M ± SD or %b p valuec

327 20.3 ± 4.0

.301

Maternal education (y)

145 5.9 ± 2.5

327 6.1 ± 3.3

.777

Maternal heighta (cm)

145 150.7 ± 5.5

327 150.3 ± 5.4

.443

Maternal prepregnancy BMIa (kg/m2)

145 19.5 ± 2.5

327 19.9 ± 2.6

.185

Mother nulliparousa (%)

145 57.2

327 49.6

.718

Household asset index scorea

145 −0.4 ± 1.8

327 -0.1 ± 2.3

.159

HFIAS scorea (0–27)

145 3.2 ± 4.2

327 3.3 ± 4.4

.993

Sibling female (%)

145 52.4

327 52.0

.929

Birth interval between index child and sibling (m)

145 30.1 ± 7.9

327 29.7 ± 8.3

.644

Sibling age at measurement (m)

145 13.6 ± 8.1

326 13.8 ± 8.4

Maternal agea (y)

108 25.7 ± 4.5

103 25.4 4.8

a

.787
116 26.0 ± 4.5

.627

Maternal education (y)

108 8.1 ± 3.7

103 8.1 3.7

116 7.4 ± 3.2

.250

Maternal heighta (cm)

106 159.6 ± 5.2

102 159.1 6.4

115 159.7 ± 5.3

.709

Maternal prepregnancy BMIa (kg/m2)

106 24.7 ± 4.1

102 23.7 3.7

114 24.4 ± 4.4

.242

Mother nulliparousa (%)

108 42.6

103 40.8

116 31.0

.159

Household asset index scorea

108 −0.1 ± 1.0

103 0.1 1.1

116 0.0 ± 1.0

.193

HFIAS scorea (0–27)

107 2.2 ± 3.8

103 1.8 3.4

115 2.6 ± 4.0

.285

Sibling female (%)

99

109 43.1

.435

Birth interval between index child and sibling (m)

108 39.9 ± 12.7

38.4

103 36.5 ± 11.1

99

47.5

116 38.7 ± 12.0

.116

Sibling age at measurement (m)

108 22.4 ± 13.0

103 24.3 ± 12.9

116 24.6 ± 12.7

.285

Abbreviations: BMI, body mass index; HFIAS, household food insecurity access scale; IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN,
multiple micronutrient; RDNS, Rang-Din Nutrition Study.
a
Denotes baseline characteristics from the original randomized trial.
b
Values are M ± SD for continuous variables and percentage for dichotomous variables.
c
For continuous variables, p values for tests of difference in mean between groups based on mixed model linear regressions (RDNS) or ordinary least
squares regressions (DYAD-G). For dichotomous variables, p values for tests of difference in proportion between groups based on mixed model logistic
regressions (RDNS) or logit regressions (DYAD-G).

TABLE 4

Continuous younger sibling anthropometric outcomes
LNS

IFA

MMN

Trial

Variable

N

Mean (95% CI)

N

Mean (95% CI)

RDNS

HAZ/LAZ

144

−1.44 [−1.66, −1.22]

325

−1.54 [−1.70, −1.38]

.398

WAZ

145

−1.39 [−1.59, −1.19]

326

−1.40 [−1.54, −1.26]

.945

WHZ/WLZ

144

−0.81 [−0.97, −0.65]

325

−0.74 [−0.84, −0.64]

.494

BMIZ

144

−0.79 [−0.93, −0.65]

325

−0.66 [−0.76, −0.56]

.160

DYAD-G

N

Mean (95% CI)

p valueb

HCZ

145

−1.61 [−1.77, −1.45]

326

−1.64 [−1.76, −1.52]

.794

MUACZa

127

−0.53 [−0.71, −0.35]

293

−0.51 [−0.63, −0.39]

.862

HAZ/LAZ

85

−0.87 [−1.11, −0.63]

94

−0.91 [−1.15, −0.67]

96

−0.91 [−1.15, −0.67]

.964

WAZ

86

−0.57 [−0.79, −0.35]

90

−0.54 [−0.76, −0.32]

94

−0.68 [−0.90, −0.46]

.626

WHZ/WLZ

85

−0.13 [−0.35, 0.09]

90

−0.04 [−0.26, 0.18]

94

−0.25 [−0.45, −0.05]

.357

BMIZ

85

−0.03 [−0.25, 0.19]

90

0.07 [−0.15, 0.29]

94

−0.16 [−0.36, 0.04]

.322

HCZ

98

−0.84 [−1.04, −0.64]

99

−0.55 [−0.75, −0.35]

107

−0.71 [−0.89, −0.53]

.102

MUACZa

81

−0.44 [−0.62, −0.26]

86

−0.38 [−0.56, −0.20]

95

−0.58 [−0.74, −0.42]

.211

Abbreviations: BMIZ, body mass index-for age z score; HAZ/LAZ, height-for-age z score/length-for-age z score; HCZ, head circumference-for-age z score;
IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN, multiple micronutrient; MUACZ, mid-upper arm circumference-for-age z score; WAZ,
weight-for-age z score; WHZ/WLZ, weight-for-height z score/weight-for-length z score.
a
MUACZ calculated for children 3 months of age and older.
b
All models control for younger sibling age at growth measurement.
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TABLE 5

Dichotomous younger sibling anthropometric outcomes
LNS

IFA

MMN

Trial

Variable

N

Prevalence (95% CI)

N

Prevalence (95% CI)

RDNS

Stunted

144

29.2 [23.9, 34.4]

325

34.2 [28.3, 40.0]

Wasted

144

7.6 [3.8, 11.5]

325

9.2 [6.7, 11.8]

.603

Underweight

145

24.1 [18.3, 30.0]

326

28.5 [22.7, 34.3]

.418

Stunted

85

9.4 [3.2, 15.6]

94

20.2 [12.1, 28.3]

96

13.5 [6.68, 20.4]

.139

Wasted

85

1.2 [−1.1, 3.5]

90

3.3 [−0.4, 7.1]

94

2.1 [-0.79, 5.1]

.600

Underweight

86

5.8 [0.9, 10.8]

90

12.2 [5.4, 19.0]

94

11.7 [5.19, 18.2]

.305

DYAD-G

N

p valuea

Prevalence (95% CI)

.439

Note. Stunted defined as height-for-age z score/length-for-age z score < −2. Wasted defined as weight-for-height z score/weight-for-length z score < −2.
Underweight defined as WAZ < −2.
Abbreviations: IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN, multiple micronutrient; RDNS, Rang-Din Nutrition Study.
a
All models control for younger sibling age at growth measurement.

and birth interval) of the younger siblings in both the RDNS and

As shown in Tables S7 and S8 in the OSM, these findings did not

DYAD-G follow-up samples of younger siblings with anthropometric

change for either RDNS or DYAD-G based on the fully adjusted

measurements. The average birth interval between the index child

models that controlled for predefined baseline covariates. The results

and the younger sibling was ~30 months in the RDNS sample and

of the per-protocol analyses are shown in Tables S9 and S10 in the

~39 months in the DYAD-G sample.

OSM. Among just the sample of siblings for whom the mother
reported consuming her assigned supplement on at least 60% of the
days during pregnancy and the postpartum period of supplementa-

3.2

|

Younger sibling growth

tion, there were no group differences in any of the continuous or
dichotomous outcomes in either the RDNS or DYAD-G samples.

The effects of the intervention on continuous and dichotomous sib-

Finally, Tables S11 and S12 in the OSM show the effects on the

ling growth status outcomes are shown in Tables 4 and 5, respec-

continuous and dichotomous, respectively, DYAD-G sibling growth

tively. Among younger siblings in the RDNS follow-up sample, who

status outcomes on the basis of the “as received” analyses in which

were on average 13.8 months (standard deviation of 8.3) of age at

group assignments correspond to the supplements women actually

measurement, there were no significant differences in any of the con-

received at enrollment in Ghana. These results showed a difference in

tinuous growth status outcomes between siblings of mothers who

the mean HCZ among groups (p = .042). Pairwise group comparisons,

received LNS in the previous pregnancy and the first 6 months post-

corrected for multiple hypothesis testing using the Tukey–Kramer

partum compared with siblings of mothers who received IFA. Like-

adjustment, showed the mean HCZ was significantly lower in the LNS

wise, there were no differences in the prevalence of stunting, wasting,

group compared with the MMN group (estimated difference in mean

or underweight between the two groups. Tables S3 and S4 in the

HCZ of −0.32 [−0.63, −0.01], p = .043).

OSM show that, comparing the four RDNS child intervention arms,
there were no differences in the continuous and dichotomous outcomes, respectively. The observed intracluster correlation for each

4

|

DI SCU SSION

outcome was essentially zero.
Among younger siblings in the DYAD-G follow-up sample, who

Although there is increasing recognition of the potential importance

were on average 21.2 months (standard deviation of 13.4) of age at

of maternal preconception nutrition for birth outcomes and child

measurement, the continuous and dichotomous growth status out-

growth, there is relatively little evidence directly evaluating the effect

comes were not significantly different among the LNS, MMN, and IFA

of interventions that improve maternal nutrition during the precon-

groups. Notably, however, there was a substantial difference in the

ception period on these outcomes. The analyses presented here eval-

prevalence of stunting in the LNS group compared with the IFA group

uated

(9.4% in the LNS group vs. 20.2% in the IFA group; relative risk 0.53

supplementation during pregnancy and postpartum on the growth sta-

[0.25, 1.46]), though the difference was not statistically significant (p =

tus of the next child born after the index pregnancy/postpartum

.139). Tables S5 and S6 show the DYAD-G results comparing the LNS

period. In both Bangladesh and Ghana, overall we found no differ-

group with the combined IFA and MMN groups. There were no differ-

ences in growth status or the prevalence of undernutrition among

ences between these two groups in any of the continuous or dichoto-

younger siblings whose mothers had received LNS (or MMN in Ghana)

mous outcomes, but again, there was a notable difference that did not

during the index pregnancies and postpartum periods, compared with

reach statistical significance in stunting between groups (9.4% in the

younger siblings of mothers who had received IFA. However, in both

LNS group vs. 16.8% in the combined IFA + MMN group, p = 095).

Bangladesh and Ghana, the prevalence of stunting was lower

the

potential

for

longer

term

benefits

of

maternal
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(5 percentage points in Bangladesh and >10 percentage points in

RDNS sample and ~25 months in the DYAD-G sample. Therefore,

Ghana) among siblings whose mothers had received LNS compared

any effect of improved maternal nutritional status at 6 months post-

with those who had received IFA, though we had relatively low power

partum may have been diminished by the time the younger sibling

to detect differences in dichotomous outcomes and these differences

was conceived.

in the prevalence of stunting were not statistically significant.

This analysis had several strengths. First, the rate of successful

Other available evidence, from three trials that started precon-

follow-up was high for both studies (~98% in RDNS and ~85% in

ception maternal supplementation at least 3 months prior to concep-

DYAD-G). Another strength was that the differences between the

tion, is mixed. A recent multicountry (Democratic Republic of the

study sites in Bangladesh and Ghana improved the external validity of

Congo, Guatemala, India, and Pakistan) randomized controlled trial

our results. Bangladesh and Ghana have differing background rates of

showed no difference in birth outcomes in the group that received

maternal and child undernutrition: In Bangladesh in 2014, 36% of chil-

daily LNS starting at least 3 months before conception compared with

dren under 5 years of age were stunted, and 31% of ever-married

the group that received LNS starting late in the first trimester of preg-

women of reproductive age had low BMI (BMI < 18.5; National Insti-

nancy, though birth outcomes in both LNS groups were improved rel-

tute of Population Research and Training (NIPORT), Mitra and Associ-

ative to the control group that did not receive supplementation

ates, & ICF International, 2016), whereas in Ghana in 2014, the

(Hambidge et al., 2019). An earlier food-based intervention in India

prevalence of stunting among children under age 5 was 19%, and

showed no difference in birth weight among the infants of women

prevalence of low BMI among women of reproductive age was 6%

who were provided with a nutrient-dense daily snack prior to concep-

(Ghana Statistical Service, Ghana Health Service, & ICF International,

tion and through pregnancy, compared with the infants of women

2015). The external validity of our results was also strengthened due

provided a similar snack but with low micronutrient content (control;

to the study samples being drawn from different populations in each

Potdar et al., 2014). However, among women who began consuming

country (rural in Bangladesh and semiurban in Ghana) as well as the

the snack 90 days or more before their last menstrual period, birth

differing study designs between the two countries, with the RDNS

weight was higher in the nutritious snack group compared with the

study designed as an effectiveness trial and DYAD-G as an efficacy

control group. Finally, in a study in Vietnam that provided preconcep-

trial.

tion women with either daily IFA, daily MMN, or daily folic acid sup-

The results of these analyses are also qualified by several limita-

plements, there were no differences in birth outcomes in either the

tions. First, it is possible that some women in our samples had one or

group that received MMN or the group that received IFA compared

more pregnancy between the index child and the younger sibling

with the group that received folic acid, even among the subgroup of

included in our analyses that ended in miscarriage, stillbirth, or child

women who received their assigned supplement for at least 26 weeks

death. Pregnancy histories were collected at follow-up for the RDNS

before conception (Ramakrishnan et al., 2016). However, a follow-up

sample, and among those with a child included in this analysis, 4%

to that study found that, at 2 years of age, the children of women

reported more than one pregnancy after the index child. Although

who received preconception MMN or preconception IFA had

similar data are not available for DYAD-G, the rate is likely a bit higher

improved linear growth and reduced risk of stunting compared with

given that more time elapsed between the end of maternal supple-

those who received only folic acid (Nguyen et al., 2017).

mentation during the main trial and follow-up data collection. In these

Our findings of no intervention group differences in growth sta-

cases, the pathway between the nutritional status of the mother dur-

tus or the prevalence of undernutrition among younger siblings have

ing the index pregnancy and postpartum period and the growth status

several possible explanations. The first is that the control group in

of her next living child is less direct. Another limitation is that having

both trials received IFA, which by itself may have had a positive

another child after the index child was a choice variable, resulting in a

impact on maternal nutritional status prior to conception of the next

selected (and relatively small) sample of siblings at follow-up. In the

child. In the trial in Vietnam (Nguyen et al., 2017), preconception

RDNS sample, there was a significant by-group difference in the likeli-

MMN and IFA were both shown to improve linear growth at 2 years

hood of having a younger sibling who was measured at follow-up

of age compared with preconception folic acid alone. In our trials,

(no difference in the DYAD-G sample), and in both samples, there

the daily dose of iron contained in the IFA capsules was 60 mg,

were differences in the background characteristics of those with and

whereas the daily dose of iron in the MMN capsules and the LNS

without a younger sibling measured at follow-up. Some of these dif-

was 20 mg (Table S1). Thus, it is possible that there was no detect-

ferences, which included maternal age, maternal parity, maternal BMI,

able advantage of LNS or MMN beyond the effect of the IFA.

and house asset index score in the RDNS sample and maternal parity,

Another possibility is that improved maternal nutritional status during

maternal age, and maternal height in the DYAD-G sample, were

the trials was not sustained through conception with her next child.

expected (i.e., we would expect older mothers and multiparous

It is possible, for example, that after 6 months postpartum and the

mothers to be less likely to have another child). The other differences

end of maternal supplementation, continued demands on maternal

were generally small in magnitude, and these differences, along with

nutrient stores during the remainder of lactation could have depleted

other background characteristics, were well balanced among interven-

stores of some nutrients, such as fat-soluble vitamins. On average,

tion groups in the follow-up samples. There were also differences in

the gap between the end of maternal supplementation at 6 months

the characteristics of the follow-up and lost to follow-up samples,

postpartum and conception of her next child was ~15 months in the

though the magnitude of the differences were small. These
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differences may have implications with regard to the generalizability

Adjetey, and the team of enumerators. We would also like to

of the findings. However, because the follow-up sample of younger
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